Latest filing published 12 Sept 2025 for LifeMD, Inc., €379k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nicholas P. Alvarez (senior executive) discloses dealings in LifeMD, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 11 February 2022 to 10 September 2025.
Both buying and selling appear: 1 purchase worth €29k, against 1 sale worth €379k. Taken together, the sales exceed the purchases by €350k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants. So far in 2025, the count stands at no purchases and 1 sale.
The newest entry dates from 12 September 2025: an open-market sale of €379k, in LifeMD, Inc. The most recent open-market purchase was published on 15 June 2023, 1,221 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations